A novel high throughput screening platform reveals an optimised cytokine formulation for human hematopoietic progenitor cell expansion.
The main limitations of hematopoietic cord blood (CB) transplantation, viz. low cell dosage and delayed reconstitution, can be overcome by ex-vivo expansion. CB expansion under conventional culture causes the rapid cell differentiation and depletion of hematopoietic stem/progenitor cells (HSPC) resp...
主要な著者: | Tarunina, M, Hernandez, D, Kronsteiner-Dobramysl, B, Pratt, P, Watson, T, Hua, P, Gullo, F, Van der Garde, M, Zhang, Y, Hook, L, Choo, Y, Watt, S |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
Mary Ann Liebert, Inc
2016
|
類似資料
-
Single-cell assessment of transcriptome alterations induced by Scriptaid in early differentiated human haematopoietic progenitors during ex vivo expansion
著者:: Hua, P, 等
出版事項: (2019) -
Cryopreservation of hematopoietic stem/progenitor cells for therapeutic use.
著者:: Watt, S, 等
出版事項: (2007) -
Tailored Cytokine Optimization for ex vivo Culture Platforms Targeting the Expansion of Human Hematopoietic Stem/Progenitor Cells
著者:: André Branco, 等
出版事項: (2020-09-01) -
Increasing complexity of molecular landscapes in human hematopoietic stem and progenitor cells during development and aging
著者:: Watt, SM, 等
出版事項: (2022) -
An improved medium formulation for efficient ex vivo gene editing, expansion and engraftment of hematopoietic stem and progenitor cells
著者:: Rajeev Rai, 等
出版事項: (2023-06-01)